FORT LEE, N.J., Feb. 2 /PRNewswire-FirstCall/ -- Alpharma Inc. , a leading global specialty pharmaceutical company, announced today that Alpharma's senior management will provide an overview of the company's business at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference on Tuesday, February 7, 2006 at 8:40 am Eastern Standard Time.
This presentation will be audio webcast live and can be accessed on Merrill Lynch website at http://www.events.ml.com and will be available until February 20, 2006.
An archived version will be available for 30 days after the live presentation and can be accessed at the same location.
Alpharma press releases are also available at our website: http://www.alpharma.com.
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma has a growing branded franchise in the chronic pain market with its morphine-based extended release KADIAN(R) product. In addition, Alpharma is among the world's leading producers of several specialty pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Alpharma Inc.CONTACT: Kathleen Makrakis, VP, Investor Relations at Alpharma Inc.,+1-201-228-5085, kathleen.makrakis@alpharma.com